VIPS - SURF FREY and CPSH among pre market gainers
Clovis Oncology (CLVS) +45% meets key goal for ovarian cancer therapy in late-stage trial. Longeveron (LGVN) +36% publishes peer reviewed study of phase 1 trial results of Lomecel-B for alzheimer’s disease in alzheimer’s & dementia: the journal of the alzheimer’s association. Inspirato (ISPO) +30%. IZEA Worldwide (IZEA) +27% on Q4 results. Renalytix (RNLX) +16% on launching $30M financing package. Dare Bioscience (DARE) +14% Organon in pact with Daré Bioscience for Xaciato. Surface Oncology (SURF) +12% achieves $30 million milestone with first patient dosed in GlaxoSmithKline phase 1 study. Cepton (CPTN) +10%. CPS Technologies (CPSH) +9%. Redwire (RDW) +8%. KULR Technology (KULR) +8% provides lithium-Ion cell testing Services to NASA for upcoming Artemis Program. Singularity Future Technology (SGLY) +8%. Orbital Energy (OEG) +8% on Q4 results. FREYR Battery (FREY) +7%. Weibo (WB) +7% on $500M share repurchase program. AppHarvest (APPH) +7% after CNBC guest promotion. Vipshop Holdings (VIPS) +7% approves $1B share repurchase program. Digital Brands (DBGI) +4%. Xunlei (XNET) +6% on $20M share buyback plan. Team (TISI) +4%.
For further details see:
SURF, FREY and CPSH among pre market gainers